•
Sep 30, 2017

Cocrystal Pharma Q3 2017 Earnings Report

EPS
-$0.08
Previous year: -$0.03
+166.7%
Cash and Equivalents
$1.35M
Previous year: $5.91M
-77.2%
Free Cash Flow
-$2.19M
Previous year: -$3.16M
-30.8%
Total Assets
$122M
Previous year: $221M
-44.7%

Cocrystal Pharma

Cocrystal Pharma